FILE PHOTO: A sign outside Abbvie facility in Cambridge FILE PHOTO: A sign outside an Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo Post navigation Previous: U.S. FDA approves Genmab-AbbVie’s blood cancer therapy